<DOC>
	<DOCNO>NCT01825733</DOCNO>
	<brief_summary>Postoperative pain , great concern patient undergo spine surgery , lead common use opioid-based intravenous patient-controlled analgesia ( IV-PCA ) postoperatively . Opioid-based IV-PCA offer well pain control , could facilitate early recovery , rehabilitation increase patient satisfaction . However , use inevitably increase incidence postoperative nausea vomiting ( PONV ) , another great discomfort , high 80 % patient multiple risk factors.Therefore , consistent effort prevent PONV multimodal therapy risk stratification , modification preventive use antiemetic . Of antiemetic , 5-hydroxytryptamine ( 5-HT3 ) antagonist , especially ondansetron , commonly use extensively studied reduce PONV efficacy few side effect . [ 8 ] However , efficacy quite satisfactory come PONV associated opioid-based IV-PCA . Recently , many report compare antiemetic efficacy ondansetron 2 newly develop 5-HT3 antagonist , ramosetron palonosetron . Ramosetron know high affinity long duration bind 5-HT3 receptor , therefore exhibit potent sustain anti-emetic effect previously develop 5-HT3 antagonists.Palonosetron unique allosteric bind 5-HT3 receptor , bring high affinity , long duration action long elimination half-time.According previous study , ramosetron palonosetron show superior antiemetic efficacy PONV associate opioid-based IV-PCA ondansetron expect theoretical advantage . However , never evaluate one superior antiemetic efficacy opioid-based IV-PCA associate PONV . Therefore , study , tried evaluate relative antiemetic efficacy ramosetron palonosetron control opioid-based IV-PCA related PONV .</brief_summary>
	<brief_title>Comparison Palonosetron Ramosetron Preventing Patient-controlled Analgesia Related Nausea Vomiting Following Spine Surgery</brief_title>
	<detailed_description />
	<mesh_term>Nausea</mesh_term>
	<mesh_term>Vomiting</mesh_term>
	<mesh_term>Postoperative Nausea Vomiting</mesh_term>
	<mesh_term>Palonosetron</mesh_term>
	<mesh_term>Ramosetron</mesh_term>
	<criteria>1. patient ( 2065 year ) schedule lumbar spinal surgery prone position August 2011 July 2012 . 2 . All patient use opioidbased IVPCA postoperatively pain control 1. gastrointestinal disease 2. renal dysfunction 3. hepatic dysfunction 4. diabetes mellitus insulin 5. pregnancy 6. use steroid , opioid , antiemetic within 1 day surgery 7. inability understand verbal rating scale ( VRS ) 8. inability use PCA device</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>palonosetron , ramosetron , PONV , opioid</keyword>
</DOC>